CD11c+ and IRF8+ cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy.

Saved in:
Bibliographic Details
Title: CD11c+ and IRF8+ cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy.
Authors: Tse BCY; Bowel Cancer and Biomarker Laboratory, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia., Bergamin S; Department of Radiation Oncology, Royal North Shore Hospital, Sydney, Australia., Steffen P; Bowel Cancer and Biomarker Laboratory, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia., Hruby G; Department of Radiation Oncology, Royal North Shore Hospital, Sydney, Australia., Pavlakis N; Department of Medical Oncology, Royal North Shore Hospital, Sydney, Australia.; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia., Clarke SJ; Department of Medical Oncology, Royal North Shore Hospital, Sydney, Australia.; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia., Evans J; Colorectal Surgical Unit, Royal North Shore Hospital, Sydney, Australia., Engel A; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia.; Colorectal Surgical Unit, Royal North Shore Hospital, Sydney, Australia., Kneebone A; Department of Radiation Oncology, Royal North Shore Hospital, Sydney, Australia.; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia., Molloy MP; Bowel Cancer and Biomarker Laboratory, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
Source: Oncoimmunology [Oncoimmunology] 2023 Jul 20; Vol. 12 (1), pp. 2238506. Date of Electronic Publication: 2023 Jul 20 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2162-402X
DOI:10.1080/2162402X.2023.2238506